Codi QR

Virtual Inhibitory Quotient Predicts Response to Ritonavir Boosting of Indinavir-Based Therapy in Human Immunodeficiency Virus-Infected Patients with Ongoing Viremia

Depending on the degree of underlying resistance present, optimization of the pharmacokinetics of protease inhibitors may result in improved virologic suppression. Thirty-seven human immunodeficiency virus (HIV)-infected subjects who had chronic detectable viremia and who were receiving 800 mg of in...

Descripció completa

Guardat en:
Publicat a:Antimicrob Agents Chemother
Autors principals: Shulman, Nancy, Zolopa, Andrew, Havlir, Diane, Hsu, Ann, Renz, Cheryl, Boller, Sheila, Jiang, Ping, Rode, Richard, Gallant, Joel, Race, Elizabeth, Kempf, Dale J., Sun, Eugene
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2002
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC132776/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12435695/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.12.3907-3916.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars